Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 06:01 ET | Source: NUCLIDIUM AG

NUCLIDIUM Presents Positive Phase I/II Results for First Copper-based PET Diagnostic in Neuroendocrine Tumors at EANM Congress 2025

61Cu-TraceNETTM showed an excellent safety profile and was well tolerated with rapid blood clearance and a favorable half-life enabling broader biodistribution and extending time points for...